Follow us on Twitter LinkedIn

 
  • “Thank you very much for you to invite me to your excellent conference. I enjoyed it very much”.
    (Huaizheng Peng, GM, China Medical System Holdings)
  • "The conference was a really interesting blend of top class panel discussions and presentations from eminent industry professionals. I enjoyed the informal setting which enabled a great two way interaction and came back with knowledge and good contacts."
    (Rahul Garella, Former Senior Vice President, Glenmark Generics Europe)
  • “Interesting presentations at an exciting location”.
    (Frank Grams,VP, Head Alliance Management and Business Transactions, Sanofi R&D)
  • “The congress ran smoothly and we couldn’t have been looked after any better. My colleague Elena found the day extremely interesting”
    (Ali Whittaker and Fiona Gardner, Pharmatelevision)
  • “It was a pleasure attending the WPLC 2014 in London. I very much enjoyed the panels during this informative and productive event. Congratulations on the excellent organization. WPLC is a great opportunity to exchange best practice and discuss strategic business development topics with world class organizations and high caliber executives”
    (Cristiano Musso, VP, Head Corporate Licensing, Grünenthal GmbH)
  • “Thanks for putting on such a great event! I found it very informative and look forward to attending again next year!”
    (Alex Barker, Business Development Director, GBI)
  • “It was a good conference, I enjoyed it”
    (Phil L'Huillier, Director Business Management, Cancer Research Technology Ltd)
  • “’World Pharma Licensing Congress 2014 is great event for Pharma business, the speakers were well known expert and have their word in Licensing field ,the networking opportunities during the event were very valuable”’
    (Gharib Amer, Managing Director, Suecal)
  • “Speakers were excellent and the fact that is attracted so many key stakeholders in pharma licensing meant that there were also excellent networking opportunities.”
    (Dr Angela Kukula, Director of Enterprise, The Institute of Cancer Research)
  • “An excellent platform to share EFPIA’s strategy for health and growth in Europe (#HealthyEU) with the pharmaceutical industry and stakeholders.”
    (Liam English, Communications Director, EFPIA)
 
 
Register For WPLC 2015


The World Pharma Licensing Congress
10th February 2015

 
 
 
JOIN US
 
 
 
2015 SPEAKERS
 
 
 
WPLC 2014 Executive Report
 
 

Gustavo Alcocer
Olivares

Morris Berrie
Tech Transfer Ltd

Peter Bogaert
Covington & Burling
     

Christine Bond
Royal Pharmaceutical Society Expert Advisory Panel for Science

Dr Ian Bryan
GE Healthcare

Lee Chapman
J A Kemp
     

Matthias Heck
German Pharmaceutical Industry Association

Anthony Hoerning

Iqbal Hussain
Johnson & Johnson Innovation
     

Andrew Jenner
EFPIA

Anatole  Krattiger
WIPO

Ewan Livesey
Lupin Atlantis
     

Philippe Lopes-Fernandes
EMD Serono

Arturo Lucas
Chemo Group

Axel Maibuecher, MSc PhD
Novartis Pharma AG
     

Dr Sumit Munjal
Takeda Pharmaceuticals

Tim Musoni
Royaltystat LLC

Daniel Neuman, Ph.D.
Global Prior Art
     

Peter Nolan
Oxford BioMedica

Dr Ash Patel
ERA Consulting

Daniel Perez
Marblar
     

Ajan Reginald
Cell Therapy Ltd

Lillian Safran Shaked
Shaked & Co. Law Offices

Sally Shorthose
Bird & Bird
     

Warwick Smith
British Generic Manufacturers Association

Richard Taylor
Eisai Pharmaceuticals

Colin Terry
Deloitte LLP
     

Christoph Volpers
Teva Pharmaceuticals Industries

Andreas N. Wiegand
Mitsubishi Tanabe Pharma GmbH
     
 
 
WPLC 2015 - Partners
 
 
 
2015 Industry & Media Partners
 
 
 
WPLC 2014 Interviews

 
 
 
 
 
 
WPLC SUMMIT - 2015. Copyright 2015. All Rights Reserved